Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for China Pharma Holdings (CPHI) over the last 14 years, with Q3 2025 value amounting to $3.9 million.

  • China Pharma Holdings' Shares Outstanding (Weighted Average) rose 12384.86% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 12384.86%. This contributed to the annual value of $17.5 million for FY2024, which is 41613.26% up from last year.
  • As of Q3 2025, China Pharma Holdings' Shares Outstanding (Weighted Average) stood at $3.9 million, which was up 12384.86% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Shares Outstanding (Weighted Average) ranged from a high of $46.0 million in Q3 2021 and a low of $1.1 million during Q4 2022
  • Over the past 5 years, China Pharma Holdings' median Shares Outstanding (Weighted Average) value was $3.4 million (recorded in 2023), while the average stood at $10.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first crashed by 8960.76% in 2022, then skyrocketed by 41613.26% in 2024.
  • Over the past 5 years, China Pharma Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $4.6 million in 2021, then plummeted by 77.21% to $1.1 million in 2022, then soared by 221.82% to $3.4 million in 2023, then surged by 416.13% to $17.5 million in 2024, then plummeted by 77.82% to $3.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $3.9 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.3 million in Q1 2025.